Marvin L. White
Net Worth

Last updated:

What is Marvin L. White net worth?

The estimated net worth of Mr. Marvin L. White is at least $7,745,871 as of 3 Mar 2024. He owns shares worth $576,871 as insider, has earned $293,000 from insider trading and has received compensation worth at least $6,876,000 in Aptevo Therapeutics Inc..

What is the salary of Marvin L. White?

Mr. Marvin L. White salary is $859,500 per year as Pres, Chief Executive Officer & Director in Aptevo Therapeutics Inc..

How old is Marvin L. White?

Mr. Marvin L. White is 63 years old, born in 1962.

What stocks does Marvin L. White currently own?

As insider, Mr. Marvin L. White owns shares in one company:

Company Title Shares Price per share Total value
Aptevo Therapeutics Inc. (APVO) Pres, Chief Executive Officer & Director 293,603 $1.96 $576,871

What does Aptevo Therapeutics Inc. do?

Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelodysplastic syndrome. The company's preclinical candidates also include ALG.APV-527, an investigational bispecific ADAPTIR candidate that features a mechanism of action to target 4-1BB (CD137) and 5T4, a tumor antigen expressed in various types of cancers; and APVO603, a dual agonist bispecific antibody to target 4-1BB and OX40. It also develoes APVO442, a bispecific candidate based on the ADAPTIR-FLEX platform technology to enhance biodistribution of drugs to PSMA positive tumors for treatment of prostate cancer. The company has a collaboration and option agreement with Alligator Bioscience AB to develop ALG.APV-527. Aptevo Therapeutics Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

APVO logo
APVO
Aptevo Therapeutics Inc.
$1.96

Marvin L. White insider trading

Aptevo Therapeutics Inc.

Mr. Marvin L. White has made only one insider trade between 2017-2024, according to the Form 4 filled with the SEC.

As of 3 Mar 2024 he still owns at least 293,603 units of APVO stock.

Transaction Date Security Shares Price per share Total value Source
Option
Restricted Stock Unit 9,584 N/A N/A
Option
Common Stock 9,584 $0 $10
Option
Common Stock 12,917 $0 $13
Option
Restricted Stock Unit 12,917 N/A N/A
Option
Restricted Stock Unit 4,792 N/A N/A
Option
Common Stock 4,792 $0 $5
Option
Common Stock 9,582 N/A N/A
Option
Restricted Stock Unit 9,582 N/A N/A
Option
Restricted Stock Unit 4,791 N/A N/A
Option
Common Stock 4,791 N/A N/A
Option
Common Stock 4,792 N/A N/A
Option
Restricted Stock Unit 4,792 N/A N/A
Purchase
Common Stock 50,000 $0.88 $44,000
Purchase
Common Stock 30,000 $0.81 $24,300
Purchase
Common Stock 10,000 $0.78 $7,800
Purchase
Common Stock 10,000 $2.38 $23,800
Option
Restricted Unit Stock 35,644 N/A N/A
Option
Common Stock 35,644 N/A N/A
Sale
Common Stock 100,000 $2.93 $293,000
Purchase
Common Stock 100,000 $2.93 $293,000
Option
Common Stock 53,471 N/A N/A
Option
Restricted Stock Unit 53,471 N/A N/A

Aptevo Therapeutics key executives

Aptevo Therapeutics Inc. executives and other stock owners filed with the SEC: